activity
20212025
most citedBeyond the classical type I error: Bayesian metrics for Bayesian designs using informative priors

2 citations · 3 across the 4 of their papers we have counts for

collaborators
Showing 2021Show all

2 papers · 1 filter

stat.ME2021

A Comparison of Various Aggregation Functions in Multi-Criteria Decision Analysis for Drug Benefit-Risk Assessment

Tom Menzies, Gaelle Saint-Hilary, Pavel Mozgunov

Multi-criteria decision analysis (MCDA) is a quantitative approach to the drug benefit-risk assessment (BRA) which allows for consistent comparisons by summarising all benefits and…

stat.ME2021

A Comparison of Model-Free Phase I Dose Escalation Designs for Dual-Agent Combination Therapies

Helen Yvette Barnett, Matthew George, Donia Skanji +3

It is increasingly common for therapies in oncology to be given in combination. In some cases, patients can benefit from the interaction between two drugs, although often at the ri…